A detailed history of Black Rock Inc. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,148,505 shares of HROW stock, worth $73.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,148,505
Previous 2,182,758 1.57%
Holding current value
$73.5 Million
Previous $28.9 Million 55.42%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$10.0 - $21.64 $342,530 - $741,234
-34,253 Reduced 1.57%
2,148,505 $44.9 Million
Q1 2024

May 10, 2024

SELL
$9.3 - $13.23 $351,354 - $499,829
-37,780 Reduced 1.7%
2,182,758 $28.9 Million
Q4 2023

Feb 13, 2024

BUY
$8.1 - $16.36 $1.55 Million - $3.13 Million
191,440 Added 9.43%
2,220,538 $24.9 Million
Q3 2023

Nov 13, 2023

BUY
$14.03 - $22.08 $3.36 Million - $5.29 Million
239,716 Added 13.4%
2,029,098 $29.2 Million
Q2 2023

Aug 11, 2023

BUY
$17.37 - $28.08 $22.5 Million - $36.3 Million
1,293,806 Added 261.07%
1,789,382 $34.1 Million
Q1 2023

May 12, 2023

BUY
$13.84 - $21.46 $672,056 - $1.04 Million
48,559 Added 10.86%
495,576 $10.5 Million
Q4 2022

Feb 13, 2023

BUY
$10.28 - $14.78 $123,668 - $177,803
12,030 Added 2.77%
447,017 $6.6 Million
Q3 2022

Nov 14, 2022

SELL
$6.57 - $24.88 $11,109 - $42,072
-1,691 Reduced 0.39%
434,987 $5.25 Million
Q2 2022

Aug 12, 2022

BUY
$5.75 - $7.74 $862 - $1,161
150 Added 0.03%
436,678 $3.18 Million
Q1 2022

May 12, 2022

BUY
$6.77 - $8.66 $35,616 - $45,560
5,261 Added 1.22%
436,528 $2.98 Million
Q4 2021

Feb 10, 2022

BUY
$8.5 - $12.0 $139,238 - $196,572
16,381 Added 3.95%
431,267 $3.73 Million
Q3 2021

Nov 09, 2021

BUY
$6.99 - $10.6 $7,136 - $10,822
1,021 Added 0.25%
414,886 $3.77 Million
Q2 2021

Aug 11, 2021

BUY
$6.68 - $11.07 $2.76 Million - $4.58 Million
413,865 New
413,865 $3.85 Million

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $926M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.